TNDM
the council passes — AVOIDTandem Diabetes Care, Inc.·Healthcare
Doesn't clear the council's bar right now.
27/100F
Price at last run$15.09as of Jul 8, 2026
healthcare✕Why not
The honest case against — what most tools hideMain riskno obvious red flag
Quality concernNot consistently profitable yet.
LeverageCarries meaningful debt (debt/equity 2.0).
Falling knifeDown 47% from its 1-year high — momentum is against it.
What keeps us out
- Debt rising faster than cash flow.
Patience price & distance
as of Jul 8, 2026 runThe patience price is where value discipline would let the council in — deliberately strict: we'd rather miss ten winners than own one loser.
Catalyst
none yet
A catalyst is a plausible reason the gap could close — never a certainty.